General Information
Get notified when Anteris Technologies moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Anteris Technologies
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
United States Market
Biotechnology
About Anteris Technologies
Taxonomy: structural heart, health solutions, aortic stenosis, DurAVR, Transcatheter Heart Valve, THV System, biomimetic design, cardiology, innovation, TAVR, TAVI, aortic valve, heart surgery, ASX: AVR
Funding Rounds & Investors (2)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Post-IPO Equity | •••••• | 2 |
|
09 Feb 2023 |
| Post-IPO Debt | •••••• | 1 |
|
01 Oct 2017 |
Anteris Technologies Alternatives & Competitors
Pioneering non-surgical heart valve replacement with breakthrough catheter-based technology.
Thubrikar Aortic Valve is a privately held medical device company on a mission to revolutionize the...
Heart valves for life, for patients of any age, including children
FAQ About Anteris Technologies
Don't just browse. Track.
Signal Tracker monitors Anteris Technologies and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.